Vertically integrated cannabis company
Aleafia Health Inc. (TSX:AH) (OTCQX:ALEAF) is expanding its global distribution network via a deal with Apipharm Veletrgovina d.o.o.
Aleafia agreed to supply the Europe-based pharmaceutical producer and distributor with dried cannabis flower under the three-year agreement.
The cannabis is cultivated at the company’s Niagara greenhouse facility.
According to a Friday press release, Apipharm Veletrgovina already ordered 1,000 kilograms of dried cannabis flower.
The Toronto-based company expects to ship the initial purchase order as early as the end of the first quarter of the current year.
Apipharm CEO Matevz Pompe said that teaming up with the Canadian cannabis supplier will “strengthen our market position in the development of advanced pharmaceutical formulations.”
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Aleafia Health Enters Definitive Supply Agreement with European Pharmaceutical Producer Apipharm
Aleafia Health Inc.January 8, 2021 GMT New international agreement strengthens Aleafia Health’s global distribution network
Initial purchase order for 1,000 kg of dried cannabis flower, with fulfilment of order underway
Apipharm a leading European natural pharmaceutical company with distribution in nine countries
TORONTO, Jan. 08, 2021 (GLOBE NEWSWIRE) Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) has entered into a definitive three-year cannabis supply agreement (the “Supply Agreement”) with Apipharm Veletrgovina d.o.o. (“Apipharm”) a leading European pharmaceutical producer and distributor.